Switzerland
# |
Name |
Interest Coverage Ratio |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
939.21
|
Dec. 31, 2023 | USD 165.26 | 1.08% |
|
Switzerland |
|
2 |
165.14
|
Dec. 31, 2023 | USD 179.67 | -1.84% |
|
Switzerland |
|
3 |
90.76
|
Dec. 31, 2023 | USD 87.62 | 1.69% |
|
Switzerland |
|
4 |
48.15
|
Dec. 31, 2023 | USD 561.20 | 0.41% |
|
Switzerland |
|
5 |
23.82
|
March 31, 2024 | USD 342.71 | 1.66% |
|
Switzerland |
|
6 |
17.25
|
March 31, 2024 | USD 398.72 | 2.69% |
|
Switzerland |
|
7 |
14.99
|
Dec. 31, 2023 | USD 345.60 | 2.71% |
|
Switzerland |
|
8 |
14.56
|
Dec. 31, 2024 | USD 109.34 | 3.55% |
|
Switzerland |
|
9 |
11.48
|
March 31, 2024 | USD 197.09 | 1.20% |
|
Switzerland |
|
10 |
8.01
|
Dec. 31, 2023 | USD 78.19 | 0.12% |
|
Switzerland |
|
11 |
6.62
|
Dec. 31, 2023 | USD 75.75 | -0.61% |
|
Switzerland |
|
12 |
6.39
|
Dec. 31, 2024 | USD 679.88 | 1.57% |
|
Switzerland |
|
13 |
5.40
|
Dec. 31, 2023 | USD 92.96 | 1.64% |
|
Switzerland |
|
14 |
1.47
|
Dec. 31, 2023 | USD 45.50 | 0.26% |
|
Switzerland |
|
15 |
-5.12
|
Dec. 31, 2023 | USD 22.25 | 0.61% |
|
Switzerland |
|
16 |
-24.18
|
Dec. 31, 2023 | USD 25.29 | -1.32% |
|
Switzerland |
|
17 |
-1,263.98
|
Dec. 31, 2023 | USD 4.99 | 1.08% |
|
Switzerland |
The Eyewear company in Switzerland with the highest Interest Coverage Ratio is IVF Hartmann Holding AG (Swiss Stock Exchange: VBSN.SW) at 939.21.
The Eyewear company in Switzerland with the lowest Interest Coverage Ratio is Molecular Partners AG (Swiss Stock Exchange: MOLN.SW) at -1,263.98.
The top 10 Eyewear companies in Switzerland by Interest Coverage Ratio are IVF Hartmann Holding AG, The Swatch Group AG, Orell Füssli AG, Vaudoise Assurances Holding SA, Sonova Holding AG, Ypsomed Holding AG, Roche Holding AG, Novartis AG, Compagnie Financière Richemont SA and DKSH Holding AG.
The bottom 10 Eyewear companies in Switzerland by Interest Coverage Ratio are Molecular Partners AG, CALIDA Holding AG, DocMorris AG, Avolta AG, Alcon Inc., Lonza Group AG, Medartis Holding AG, DKSH Holding AG, Compagnie Financière Richemont SA and Novartis AG.